667, L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 208,831 shares at $72.02 ($15.0M) on 2019-01-24, disclosed to the SEC on 2019-01-25.
Open-market sale of $15.0M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.52 | 29,260 | $2.1M | 13.8% |
| 2 | $70.52 | 34 | $2K | 0.0% |
| 3 | $70.52 | 450 | $32K | 0.2% |
| 4 | $70.52 | 502 | $35K | 0.2% |
| 5 | $70.52 | 774 | $55K | 0.4% |
| 6 | $70.52 | 4,492 |
| $317K |
| 2.1% |
| 7 | $73.46 | 2 | $147 | 0.0% |
| 8 | $73.46 | 25 | $2K | 0.0% |
| 9 | $73.46 | 28 | $2K | 0.0% |
| 10 | $73.46 | 1,648 | $121K | 0.8% |
| 11 | $73.46 | 44 | $3K | 0.0% |
| 12 | $73.46 | 253 | $19K | 0.1% |
| 13 | $72.02 | 76 | $5K | 0.0% |
| 14 | $72.02 | 1,004 | $72K | 0.5% |
| 15 | $72.02 | 1,121 | $81K | 0.5% |
| 16 | $72.02 | 1,732 | $125K | 0.8% |
| 17 | $72.02 | 10,044 | $723K | 4.8% |
| 18 | $72.02 | 65,426 | $4.7M | 31.4% |
| 19 | $72.20 | 89 | $6K | 0.0% |
| 20 | $72.20 | 1,162 | $84K | 0.6% |
| 21 | $72.20 | 1,298 | $94K | 0.6% |
| 22 | $72.20 | 2,004 | $145K | 1.0% |
| 23 | $72.20 | 11,627 | $839K | 5.6% |
| 24 | $72.20 | 75,736 | $5.5M | 36.4% |
| Total | $71.86 avg | 208,831 | $15.0M | 100% |
| Filing → |
| MDGL | BUY | 2023-12-14 | $14.7M | — | Filing → |
| ACAD | BUY | 2023-05-24 | $45.4M | — | Filing → |
| TCRX | BUY | 2022-05-12 | $4.8M | — | Filing → |